STAQ Pharma

A brand new 503B outsourcing facility.

  • Setting the bar higher.

    Independent testing analysis to ensure stability, sterility, potency and lack of endotoxins. Integrated robotics. Read more…

    Setting the bar higher.

  • Working to eliminate shortage.

    Anesthesia medication designed by you. For you. Inventory systems to forecast needs and provide critical product. Read more…

    Working to eliminate shortage issues.

  • Let’s be clear.

    Designed and built from the floor up to comply with 503B regulations, our cGMP facility has nothing to hide. Read more…

    Let’s be clear.

  • Safety matters.

    Pediatric concentrations. Created specifically for pediatric patients. Developed with guidance from Children’s Hospital Colorado. Read more…

    Safety matters.

Welcome to STAQ.

Bringing safety, transparency, availability and quality to compounded medications.

Become a customer today!

SAFETY

Providing the right dosage of medication available in pre-filled syringes produced in a sterile, cGMP-compliant 503B facility gives doctors – and their patients – an added level of safety and confidence in the operating room.

TRANSPARENCY

From the glass panes in our pharmaceutical facility to the COAs (certificate of analysis) we provide with every batch and detailed quarterly quality management reports we post online, STAQ is committed to transparency.

AVAILABILITY

Having the IV push medication you need available when you need it is, simply put, essential. That’s why we’ve put systems in place to help support and even anticipate your compounded pharmaceutical needs.

QUALITY

STAQ’s goal from day one has been to help ensure the highest quality compounded medications for children and adults. Built brand new as a 503B, and focused on the most current FDA guidance, we’re poised to do just that.

Our Capabilities

Designed and built from the start for cGMP compliance, STAQ’s brand new 503B pharmaceutical outsourcing facility is leading a new generation of sterile, injectable medical compounding.

  • Pre-filled pediatric and adult concentrations
  • Robotic automation for sterility and precision
  • COAs provided with every batch
  • Capacity to produce up to 30,000 syringes/day
  • State-of-the-art manufacturing
  • Onsite inspection room
One-page summary of STAQ capabilities

STAQ’s Latest News and Activity

CNN reports on Albuterol Shortage

A recent CNN Health report highlights the ongoing shortage of albuterol, noting STAQ’s partnership with the Children’s Hospital Association in …

Read More

The Albuterol shortage is worsening

With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according …

Read More

View all news